Thomas C King MD, PhD

Degree(s) – MD, PhD

Academic Title – Associate Professor

Education/Training – Board Certified in Anatomic Pathology, 1988; FCAP

Washington University , St. Louis , MO	AB	1975-1978	Biology
Washington University , St. Louis , MO	PhD	1978-1984	Molecular Biology
Washington University , St. Louis , MO	MD	1978-1984	Medicine
Washington University Medical Center , St. Louis , MO		1984-1987	Pathology Residency
University of Connecticut		1987-1988	Exp. Pathology

Research Interests – Molecular Pathology

Recent Publications –

King TC . Akerley W. Fan AC. Moore T. Mangray S. Hsiu Chen M. Safran H. p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma. Cancer. 89(4):769-73, 2000

Elenitoba-Johnson KS . Bohling SD. Wittwer CT. King TC . Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis. Nature Medicine. 7(2):249-53, 2001

Safran H. Steinhoff M. Mangray S. Rathore R. King TC . Chai L. Berzein K. Moore T. Iannitti D. Reiss P. Pasquariello T. Akerman P. Quirk D. Mass R. Goldstein L. Tantravahi U. Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma. American Journal of Clinical Oncology. 24(5):496-9, 2001

Shrayer DP. Lukoff H. King T . Calabresi P. The effect of Taurolidine on adherent and floating subpopulations of melanoma cells. Anti-Cancer Drugs. 14(4):295-303, 2003